Matthias Schmitt

Featured in: Favicon

nature.com Favicon

science.org Favicon

diabetesjournals.org Favicon

unirioja.es Favicon

aacrjournals.org Favicon

emeraldgrouppublishing.com Favicon

onlinelibrary.wiley.com Favicon

heart.bmj.com + 3 more

Articles

Considerations for drug trials in hypertrophic cardiomyopathy

Oct 27, 2024 | onlinelibrary.wiley.com | John Farrant |Matthias Schmitt |Anna Reid |Clifford Garratt

Introduction Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disorder, characterized by cardiomyocyte disarray, left ventricular (LV) hypertrophy, small vessel disease and myocardial fibrosis.1, 2 Clinical manifestations are variable.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →